ANI Pharmaceuticals, Inc. (ANIP)
76.50
-1.79
(-2.29%)
USD |
NASDAQ |
Apr 15, 16:00
76.50
0.00 (0.00%)
After-Hours: 18:30
ANI Pharmaceuticals Research and Development Expense (Annual) : 51.66M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Liquidia Corp. | 38.45M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Indivior Pharmaceuticals, Inc. | 80.00M |
| Replimune Group, Inc. | 191.22M |
| ADMA Biologics, Inc. | 4.762M |